May 2020 Clinical Watch Newsletter

June 17, 2020

In this issue of Clinical Watch, we highlight the use of diabetes drugs in the treatment of heart failure and suggest prior authorization criteria for the first approved treatment of plexiform neurofibromas. Lastly, we review claims data to identify potential users for a new option to treat “off” episodes associated with Parkinson’s disease.

For more information about a specific topic, please contact Janelle Sheen or Karen Powell. Be sure to stay tuned for future monthly updates. For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Article
Galvanizing Constituent-Centered, Strategic Public Sector EBT Services
Galvanizing Constituent-Centered, Strategic Public Sector EBT Services

Next Article
How Dads Make a Difference – on Father’s Day and Every Day
How Dads Make a Difference – on Father’s Day and Every Day